Search Results - "England, Ross"
-
1
Interleukin-19 induces angiogenesis in the absence of hypoxia by direct and indirect immune mechanisms
Published in American Journal of Physiology: Cell Physiology (01-06-2016)“…Neovascularization and inflammation are independent biological processes but are linked in response to injury. The role of inflammation-dampening cytokines in…”
Get more information
Journal Article -
2
Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model
Published in npj vaccines (18-06-2024)“…Maternal antibodies (matAbs) protect against a myriad of pathogens early in life; however, these antibodies can also inhibit de novo immune responses against…”
Get full text
Journal Article -
3
Pearls & Oy-sters: Bilateral globus pallidus lesions in a patient with COVID-19
Published in Neurology (08-09-2020)Get full text
Journal Article -
4
Induction of MiR133a expression by IL-19 targets LDLRAP1 and reduces oxLDL uptake in VSMC
Published in Journal of molecular and cellular cardiology (01-04-2017)“…Abstract The transformation of vascular smooth muscle cells [VSMC] into foam cells leading to increased plaque size and decreased stability is a key, yet…”
Get full text
Journal Article -
5
Self-Limited COVID-19 in a Patient with Artemis Hypomorphic SCID
Published in Journal of clinical immunology (01-11-2021)Get full text
Journal Article -
6
Attenuation of Experimental Atherosclerosis by Interleukin-19
Published in Arteriosclerosis, thrombosis, and vascular biology (01-10-2013)“…OBJECTIVE—Interleukin-19 (IL-19) is a putative Th2, anti-inflammatory interleukin. Its expression and potential role in atherogenesis are unknown. IL-19 is not…”
Get full text
Journal Article -
7
Interleukin-19 decreases leukocyte-endothelial cell interactions by reduction in endothelial cell adhesion molecule mRNA stability
Published in American Journal of Physiology: Cell Physiology (01-08-2013)“…Vascular endothelial cell (EC) inflammation is a key event in the pathogenesis of multiple vascular diseases. We tested the hypothesis that interleukin-19…”
Get more information
Journal Article -
8
IL-19 Reduces Ligation-Mediated Neointimal Hyperplasia by Reducing Vascular Smooth Muscle Cell Activation
Published in The American journal of pathology (01-07-2014)“…We tested the hypothesis that IL-19, a putative member of the type 2 helper T-cell family of anti-inflammatory interleukins, can attenuate intimal hyperplasia…”
Get full text
Journal Article -
9
Anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility
Published in American Journal of Physiology: Cell Physiology (01-04-2011)“…Vascular smooth muscle cell (VSMC) migration is an important cellular event in multiple vascular diseases, including atherosclerosis, restenosis, and…”
Get more information
Journal Article -
10
Increased atherosclerosis and vascular smooth muscle cell activation in AIF-1 transgenic mice fed a high-fat diet
Published in Atherosclerosis (01-01-2012)“…Abstract Allograft inflammatory factor-1 (AIF-1) is a cytoplasmic, scaffold signal transduction protein constitutively expressed in inflammatory cells, but…”
Get full text
Journal Article -
11
Anti-Inflammatory Effects of Interleukin-19 in Vascular Disease
Published in International journal of inflammation (01-01-2012)“…Despite aggressive dietary modification, lipid-lowering medications, and other interventional medical therapy, vascular disease continues to be a leading cause…”
Get full text
Journal Article -
12
Granulomatous Dermatitis Associated With Rubella Virus Infection in an Adult With Immunodeficiency
Published in JAMA dermatology (Chicago, Ill.) (01-07-2021)“…Immunodeficiency-related, vaccine-derived rubella virus (RuV) as an antigenic trigger of cutaneous and visceral granulomas is a rare, recently described…”
Get more information
Journal Article -
13
2342. Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model
Published in Open forum infectious diseases (27-11-2023)“…Abstract Background Maternal antibodies (matAbs) protect against a myriad of pathogens early in life; however, these antibodies can also inhibit de novo immune…”
Get full text
Journal Article -
14
Abstract 47: FXR1 Regulates Inflammatory MRNA Stability and VSMC Proliferation by Modulation of HuR Activity
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2017)“…Abstract only Vascular smooth muscle cells (VSMC) play a critical role in the etiology and progression of many vascular diseases including atherosclerosis and…”
Get full text
Journal Article -
15
Abstract 404: Induction of MiR133a Expression By IL-19 Targets LDLRAP1 and Reduces Oxidized LDL Uptake in VSMC
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2017)“…Abstract only Introduction: The transformation of vascular smooth muscle cells (VSMC) into foam cells leading to increased plaque size and decreased stability…”
Get full text
Journal Article -
16
Human Blood Plasma Shapes Distinct Neonatal TLR-Mediated Dendritic Cell Activation via Expression of the MicroRNA Let-7g
Published in ImmunoHorizons (30-04-2021)“…The newborn innate immune system is characterized as functionally distinct, resulting in impaired proinflammatory responses to many stimuli and a bias toward…”
Get full text
Journal Article -
17
Identifying Mechanisms of Interleukin‐19‐Mediated HuR‐Dependent Reduction in Vascular Cell mRNA Stability
Published in The FASEB journal (01-04-2013)“…Abstract only IL‐19 reduces TNF‐α‐driven mRNA abundance and protein abundance of intercellular adhesion molecule‐1 (ICAM‐1) and vascular cell adhesion…”
Get full text
Journal Article -
18
The Anti‐Inflammatory Cytokine Interleukin‐19 Inhibits Smooth Muscle Cell Migration and Activation of Cytoskeletal Regulators of VSMC Motility
Published in The FASEB journal (01-04-2011)“…Vascular Smooth Muscle Cell (VSMC) migration is an important cellular event in multiple vascular diseases. We tested the hypothesis that an anti‐inflammatory,…”
Get full text
Journal Article -
19
Abstract 79: Interleukin-19 Reduces Leukocyte-Endothelial Cell Interactions
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2012)“…Abstract only Introduction Vascular endothelial cells (EC) actively participate in the pathogenesis of atherosclerosis by increasing expression of cell…”
Get full text
Journal Article -
20
Attenuation of Experimental Atherosclerosis by Interleukin‐19
Published in The FASEB journal (01-04-2013)“…Abstract only Interleukin‐19 (IL‐19) is a Th2, anti‐inflammatory interleukin. IL‐19 is expressed in several cell types in human atherosclerotic plaque. We…”
Get full text
Journal Article